gemcitabine hydrochloride has been researched along with cytarabine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abd El-All, AS; Abdallah, MM; El-Diwani, HI; Galal, SA | 1 |
| Abdel-Mohsen, HT; El Diwani, HI; Ragab, FA; Ramla, MM | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
3 other study(ies) available for gemcitabine hydrochloride and cytarabine
| Article | Year |
|---|---|
Synthesis of potent antitumor and antiviral benzofuran derivatives.
Topics: Antineoplastic Agents; Antiviral Agents; Benzofurans; Cell Line, Tumor; Chemistry, Pharmaceutical; Drug Design; Drug Screening Assays, Antitumor; HIV Reverse Transcriptase; Humans; Inhibitory Concentration 50; Models, Chemical; Oligopeptides; Piperazines | 2009 |
Novel benzimidazole-pyrimidine conjugates as potent antitumor agents.
Topics: Antineoplastic Agents; Benzimidazoles; Cell Line, Tumor; Cell Proliferation; Humans; Lethal Dose 50; Pyrimidines | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |